Our Specialists

Dr David Prince is a consultant gastroenterologist and hepatologist with experience managing a range of common and specialist gastroenterological and liver conditions. He has a subspeciality interest in liver disease.

Dr Prince graduated from the University of New South Wales in 2012 with 1st class honours and the university medal for medicine before undertaking post graduate medical training at a range of metropolitan and regional hospitals within NSW. Dr Prince completed his advanced training in gastroenterology and hepatology at Liverpool hospital and obtained a fellowship from the Royal Australian College of Physicians (RACP) in 2019. He has subsequently completed a clinical fellowship in hepatology at Royal Prince Alfred Hospital with a focus on management of advanced liver disease.

Dr Prince currently works as a part time staff specialist (3 days per week) at Liverpool hospital. Dr Prince performs a range of endoscopic procedures and has Australian conjoint committee accreditation in both gastroscopy and colonoscopy. He is an active participant in the national colonoscopy re-certification program.

Dr Prince has a strong research interest and is also currently completed a PhD in ways to improve the clinical care of patients with liver disease. Dr Prince is actively involved in the Gastroenterological Society of Australia and is the past chair the Young GESA Network. He is current RACP clinical examiner and has previously been involved with the RACP gastroenterology Advanced Training Committee.

Bachelor of Medicine and Bachelor of Surgery (MBBS) (Hons 1M)
University of New South Wales (2012)

Master of Public Heath (MPH)
University of New South Wales (2015)

Master of Health Management (MHM)
University of New South Wales (2018)

Fellow of the Royal Australasian College of Physicians (FRACP) (2019)

PhD Candidate, Centenary Institute, Sydney University (2021 – ongoing)

Staff Specialist, gastroenterologist and hepatologist (2023 – present)
Department of gastroenterology and Liver, Liverpool hospital

Visiting Medical Officer, gastroenterologist and hepatologist (2021– 2022)
Department of gastroenterology and Liver, Liverpool hospital

Conjoint Lecturer (2021 – present)
University of New South Wales

Honorary medical officer (2021– present)
AW gastroenterology and liver centre, Royal Prince Alfred Hospital

Visiting Medical Officer, gastroenterologist and hepatologist (2020 – 2024)
Lismore Base Hospital

1. Prince D, Hoque S, Kim C, et al. (2024). Screening patients in general practice for advanced chronic liver disease using an innovative IT solution: The Liver Toolkit. Hepatol Commun 2024; 8: e0482.
   
2. Jacob R, Prince D, Pipicella J, Nguyen A, Bagatella M, Alvaro, Maley M, Foo H, Middleton P, Kayes T, DiGirolamo J, Davison D, Levy M. (2023). Routine Screening of emergency admissions at risk of chronic hepatitis (SEARCH) identifies and links hepatitis B cases to care. Liver Int, 43(1), pp.60-68.
   
3. Prince D, Schlaphoff G, Davison D, Hao R, Xiang H, Chan M, Lee A, Thailakanthan C, Jebeili H, Rogan C, Al-Omary A, Gupta S, Lockart I, Tiwari N, Clark-Dickson M, Hillhouse J, Laube R, Chang J, Nguyen V, Danta M, Cheng R, Strasser S, Zekry A, Levy M, Chan C, Liu K. (2022). Selective internal radiation therapy for hepatocellular carcinoma – A 15-year multicentre Australian cohort study. J Gastroenterol Hepatol. 37(11), 2173-2181.
   
4. Patwala K, Prince D, Celermajer Y, Alam W, Paul E, Strasser S, McCaughan G, Gow P, Sood S, Murphy E, Roberts S, Freeman E, Stratton E, Davison A, Levy M, Clark-Dickson M, Nguyen V, Bell S, Nicoll A, Bloom A, Lee A, Ryan M, Howell J, Valaydon Z, Mack A, Liu K, Dev A. (2022). Lenvatinib for the treatment of hepatocellular carcinoma – A real-world multicentre Australian cohort study. Hepatol Int. 16(5), pp.1170-1178.
   
5. Remash D, Prince D, McKenzie C, Strasser S, Kao S, Liu K. (2021). Immune checkpoint inhibitor-related hepatotoxicity: a review. World J Gastroenterol, 27 (32), 5376
   
6. Prince D, Pipicella J, Fraser M, Alvaro F, Maley M, Foo H, Middleton P, Davison S, Dore G, McCaughan, G, Levy M. (2021) Screening Emergency Admissions at Risk of Chronic Hepatitis C to diagnose or “re-diagnose” infections is effective. J Viral Hepat, 28(1):121-128
   
7. Prince D, Liu K, Xu W, Chen M, Sun J, Lu X, Ji J. (2020). Management of patients with intermediate stage hepatocellular carcinoma. Ther Adv Med Oncol, 12, 1758835920970840